MIA team shines on world stage at SMR
Read more about Melanoma Institute Australia highlights from The Society for Melanoma Research 2023 Congress held in Philadelphia.
Researchers confirm the link between balding and skin cancer
“Research into the genetic drivers of skin cancer is critical” - MIA Co-Medical Directors Prof Georgina Long AO and Prof Richard Scolyer are co-authors on this study into the link between male pattern baldness and skin cancer.
Melanoma science in race against brain cancer – National Press Club
MIA Co-Medical Directors address the National Press Club of Australia detailing world-first breakthroughs in applying melanoma science to Richard Scolyer’s brain cancer.
Cutaneous melanoma: a contemporary overview published in The Lancet
A contemporary overview of Cutaneous melanoma, co-authored by MIA, has been published in The Lancet, one of the world's leading medical journals.
Major advance for neoadjuvant treatment of melanoma
The PBAC recommends expanding current PBS listing for pembrolizumab immunotherapy to allow neoadjuvant (before surgery) treatment of resected stage IIIB-D melanoma.
Prof Richard Scolyer gains strength from widespread support
Family, friends, colleagues and MIA provide support and strength to Prof Richard Scolyer as he undergoes treatment for a glioblastoma (brain cancer).
Prof Richard Scolyer awarded IAP ‘Distinguished Pathologist’ Medal
Read more about why Prof Richard Scolyer AO received the IAP Distinguished Pathologist Medal and watch his inspiring acceptance speech.
Prof Richard Scolyer AO honoured with ASDP Founders’ Award
This is the highest award from the American Society of Dermatopathology, and recognises Prof Scolyer's significant contribution to the field of #dermatopathology.
Clarivate announce Highly Cited Researchers 2022 list
Read more about the five MIA researchers named on the Clarivate list of Highly Cited Researchers 2022.
MIA team receives 2022 Wildfire Highly Cited Publication Award
Read more about the Cancer Institute NSW Awards and the highly cited immunotherapy publication.